R Hayes, M Wawer, R Gray, J Whitworth, H Grosskurth, D Mabey
Three community trials of the impact of STD treatment interventions on HIV incidence in rural populations have been completed or are in progress in Uganda and Tanzania. Investigators from these trials met for a joint technical workshop in Baltimore in May 1996. This report summarises the consensus of the workshop, with the aim of providing useful input to research on HIV intervention strategies. Issues discussed include: (i) the role of community randomised trials; (ii) strategies for STD management; (iii) epidemiological and statistical issues in the design and analysis of community randomised trials; (iv) diagnostic methods for STDs in population surveys; (v) treatment regimens for STDs in rural Africa; and (vi) ethical issues in community trials.
{"title":"Randomised trials of STD treatment for HIV prevention: report of an international workshop. HIV/STD Trials Workshop Group.","authors":"R Hayes, M Wawer, R Gray, J Whitworth, H Grosskurth, D Mabey","doi":"10.1136/sti.73.6.432","DOIUrl":"https://doi.org/10.1136/sti.73.6.432","url":null,"abstract":"<p><p>Three community trials of the impact of STD treatment interventions on HIV incidence in rural populations have been completed or are in progress in Uganda and Tanzania. Investigators from these trials met for a joint technical workshop in Baltimore in May 1996. This report summarises the consensus of the workshop, with the aim of providing useful input to research on HIV intervention strategies. Issues discussed include: (i) the role of community randomised trials; (ii) strategies for STD management; (iii) epidemiological and statistical issues in the design and analysis of community randomised trials; (iv) diagnostic methods for STDs in population surveys; (v) treatment regimens for STDs in rural Africa; and (vi) ethical issues in community trials.</p>","PeriodicalId":12621,"journal":{"name":"Genitourinary Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/sti.73.6.432","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20503863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: To asses changes in sexual behaviour and use of contraceptive methods in Danish adolescents from the period before the advent of AIDS up to the present.
Design: Comparative study comparing data obtained from two identical cross sectional surveys
Setting: Grenaa Gymnasium, Denmark.
Subjects: 626 high school students in 1982 and 499 high school students in 1996.
Methods: An anonymous standardised self administered questionnaire handed out to high school students at Grenaa Gymnasium in spring 1982. In spring 1996 an identical questionnaire was handed out to every high school student at the same gymnasium.
Main outcome measures: Age at first sexual intercourse, contraceptive use, and reasons for choice of contraceptive strategy.
Results: Today more males had experienced the first sexual intercourse before their 16th birthday (p = 0.047) compared with 1982, the reverse held for females (p = 0.003). From 1982 to 1996 condom use increased in males with no regular partner (p = 0.009). In females with no regular partner, there was during the same period an increase in considering the condom a personal contraceptive method (p = 0.017). In 1982 and 1996 protection from sexually transmitted diseases was given as reason for the choice of contraceptive strategy by 21% and 72% of males with no regular partner (p < 0.001), and by 7% and 32% of males with a regular partner (p < 0.001). The corresponding figures for females in 1982 and 1996 were 10% and 71% (p < 0.001) for those with no regular partner and 4% and 21% (p < 0.001) for those with a regular partner.
Conclusion: Condom use has increased among adolescents with no regular partner brought up under the widespread awareness of AIDS, and the reason for this is to be protected from sexually transmitted diseases. A future decline in the incidence of various sexually transmitted diseases may be expected, and information on safe sexual practices should be continued.
{"title":"Sexual behaviour of adolescents before and after the advent of AIDS.","authors":"L Ostergaard","doi":"10.1136/sti.73.6.448","DOIUrl":"https://doi.org/10.1136/sti.73.6.448","url":null,"abstract":"<p><strong>Objectives: </strong>To asses changes in sexual behaviour and use of contraceptive methods in Danish adolescents from the period before the advent of AIDS up to the present.</p><p><strong>Design: </strong>Comparative study comparing data obtained from two identical cross sectional surveys</p><p><strong>Setting: </strong>Grenaa Gymnasium, Denmark.</p><p><strong>Subjects: </strong>626 high school students in 1982 and 499 high school students in 1996.</p><p><strong>Methods: </strong>An anonymous standardised self administered questionnaire handed out to high school students at Grenaa Gymnasium in spring 1982. In spring 1996 an identical questionnaire was handed out to every high school student at the same gymnasium.</p><p><strong>Main outcome measures: </strong>Age at first sexual intercourse, contraceptive use, and reasons for choice of contraceptive strategy.</p><p><strong>Results: </strong>Today more males had experienced the first sexual intercourse before their 16th birthday (p = 0.047) compared with 1982, the reverse held for females (p = 0.003). From 1982 to 1996 condom use increased in males with no regular partner (p = 0.009). In females with no regular partner, there was during the same period an increase in considering the condom a personal contraceptive method (p = 0.017). In 1982 and 1996 protection from sexually transmitted diseases was given as reason for the choice of contraceptive strategy by 21% and 72% of males with no regular partner (p < 0.001), and by 7% and 32% of males with a regular partner (p < 0.001). The corresponding figures for females in 1982 and 1996 were 10% and 71% (p < 0.001) for those with no regular partner and 4% and 21% (p < 0.001) for those with a regular partner.</p><p><strong>Conclusion: </strong>Condom use has increased among adolescents with no regular partner brought up under the widespread awareness of AIDS, and the reason for this is to be protected from sexually transmitted diseases. A future decline in the incidence of various sexually transmitted diseases may be expected, and information on safe sexual practices should be continued.</p>","PeriodicalId":12621,"journal":{"name":"Genitourinary Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/sti.73.6.448","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20503865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aims: To objectively assess the psychological and psychosexual morbidity of patients with vulvar vestibulitis.
Methods: 30 patients with variable degrees of vulvar vestibulitis were recruited from a vulval clinic. Each patient underwent a detailed history and clinical examination. Friedrich's criteria were used for the diagnosis of vulvar vestibulitis. Standardised questionnaires to assess psychological and psychosexual function were completed by the patient before review. These questionnaires were the STAI and a modified psychosexual questionnaire introduced by Campion.
Results: Patients experienced considerable psychological dysfunction compared with controls. All aspects of psychosexual dysfunction were affected.
Conclusions: When managing patients, psychosexual and psychological issues must be considered in addition to other conventional types of therapy. Vulvar vestibulitis may be a risk factor for developing psychosexual complications including vaginismus, low libido, and orgasmic dysfunction. Consideration of these factors must be an integral part of the management of patients with all chronic vulval conditions.
{"title":"Psychological and psychosexual aspects of vulvar vestibulitis.","authors":"D Nunns, D Mandal","doi":"10.1136/sti.73.6.541","DOIUrl":"https://doi.org/10.1136/sti.73.6.541","url":null,"abstract":"<p><strong>Aims: </strong>To objectively assess the psychological and psychosexual morbidity of patients with vulvar vestibulitis.</p><p><strong>Methods: </strong>30 patients with variable degrees of vulvar vestibulitis were recruited from a vulval clinic. Each patient underwent a detailed history and clinical examination. Friedrich's criteria were used for the diagnosis of vulvar vestibulitis. Standardised questionnaires to assess psychological and psychosexual function were completed by the patient before review. These questionnaires were the STAI and a modified psychosexual questionnaire introduced by Campion.</p><p><strong>Results: </strong>Patients experienced considerable psychological dysfunction compared with controls. All aspects of psychosexual dysfunction were affected.</p><p><strong>Conclusions: </strong>When managing patients, psychosexual and psychological issues must be considered in addition to other conventional types of therapy. Vulvar vestibulitis may be a risk factor for developing psychosexual complications including vaginismus, low libido, and orgasmic dysfunction. Consideration of these factors must be an integral part of the management of patients with all chronic vulval conditions.</p>","PeriodicalId":12621,"journal":{"name":"Genitourinary Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/sti.73.6.541","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20504346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In this article we review the field of HIV liaison psychiatry and illustrate the manner in which psychiatric care can contribute to the health and quality of life of this group of patients. To illustrate our discussion we review experience and findings in relation to affective illness, cognitive impairments, and personality disorder in HIV infection. We also highlight some of the areas where psychiatric care of people with HIV infection is unique from other types of psychiatric liaison work.
{"title":"What is the role of the HIV liaison psychiatrist?","authors":"liaison psychiatrist, B. Clark, I. Everall","doi":"10.1136/sti.73.6.568","DOIUrl":"https://doi.org/10.1136/sti.73.6.568","url":null,"abstract":"In this article we review the field of HIV liaison psychiatry and illustrate the manner in which psychiatric care can contribute to the health and quality of life of this group of patients. To illustrate our discussion we review experience and findings in relation to affective illness, cognitive impairments, and personality disorder in HIV infection. We also highlight some of the areas where psychiatric care of people with HIV infection is unique from other types of psychiatric liaison work.","PeriodicalId":12621,"journal":{"name":"Genitourinary Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84474640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
coitus. Examination revealed an inflamed, only partially retractable prepuce with a purulent subpreputial discharge. Adequate urethral swabs were unobtainable; however, a subpreputial swab for bacterial culture was performed and subsequently grew Proteus spp, Pseudomonas spp, coliform bacilli, anaerobes, and non-candida yeasts. Urine dipstick testing proved negative for sugar. He was prescribed fluconazole 150 mg immediately and metronidazole 200 mg three times daily for 1 week and advised to irrigate gently with normal saline under the prepuce. On follow up at 1 week there had been a marked improvement. The prepuce was now fully retractable, albeit with some difficulty. Urethral swabs were obtained for microscopy, chlamydia ELISA testing, and Neisseria gonorrhoeae culture all of which proved negative. On examination there was still evidence of erythema affecting the glans and prepuce but no obvious discharge. In addition, there was a large accumulation of smegma and three small "smegma stones" (fig). On further questioning he stated that he had never previously attempted to retract his foreskin and had therefore never washed the
{"title":"Balanoposthitis associated with the presence of subpreputial \"smegma stones\".","authors":"C Sonnex, P E Croucher, W G Dockerty","doi":"10.1136/sti.73.6.567","DOIUrl":"https://doi.org/10.1136/sti.73.6.567","url":null,"abstract":"coitus. Examination revealed an inflamed, only partially retractable prepuce with a purulent subpreputial discharge. Adequate urethral swabs were unobtainable; however, a subpreputial swab for bacterial culture was performed and subsequently grew Proteus spp, Pseudomonas spp, coliform bacilli, anaerobes, and non-candida yeasts. Urine dipstick testing proved negative for sugar. He was prescribed fluconazole 150 mg immediately and metronidazole 200 mg three times daily for 1 week and advised to irrigate gently with normal saline under the prepuce. On follow up at 1 week there had been a marked improvement. The prepuce was now fully retractable, albeit with some difficulty. Urethral swabs were obtained for microscopy, chlamydia ELISA testing, and Neisseria gonorrhoeae culture all of which proved negative. On examination there was still evidence of erythema affecting the glans and prepuce but no obvious discharge. In addition, there was a large accumulation of smegma and three small \"smegma stones\" (fig). On further questioning he stated that he had never previously attempted to retract his foreskin and had therefore never washed the","PeriodicalId":12621,"journal":{"name":"Genitourinary Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/sti.73.6.567","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20502899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L Ostergaard, T Agner, E Krarup, U B Johansen, K Weismann, E Gutschik
Objective: To investigate, by use of the Amplicor PCR in a routine setting, the recovery rate of Chlamydia trachomatis in ano-rectal and pharyngeal swab samples obtained from males and females attending an STD clinic in relation to sexual practices, symptoms, and signs.
Design: Data regarding sexual practices, and symptoms and signs related to the rectum and pharynx, were obtained from 196 females and 208 males, including 31 homosexuals and eight bisexuals. Swab samples were obtained from the urethra, rectum, and pharynx from all the patients. An additional endocervical swab sample was obtained from the females.
Methods: All samples were analysed by the Amplicor PCR (Roche).
Setting: Rudolph Bergh's Hospital, a clinic for sexually transmitted diseases situated in the centre of Copenhagen, Denmark.
Results: The overall prevalence of urogenital C trachomatis infection was 9.2% (37/404). The specificity of the Amplicor PCR was 100% for both ano-rectal and pharyngeal swab samples. In females three (13%) of the 23 infections were detected only by testing an ano-rectal or throat swab sample. In homosexual males two (67%) of three infections were detected only by the anorectal swab sample. Ano-rectal intercourse without use of condom was reported by 44% of females and by 52% of homosexual males. Fellatio without condom use was reported by 91% of females, and 80% of heterosexual males practised cunnilingus. Pharyngeal infection, however, occurred only in females, and the presence of pharyngeal symptoms or signs seemed predictive for pharyngeal C trachomatis infection, for which the time of incubation or colonisation exceeded 3 months. The presence of ano-rectal signs or symptoms was not predictive for an ano-rectal C trachomatis infection.
Conclusion: The Amplicor PCR can be used on ano-rectal and pharyngeal swab samples. Ano-rectal swab samples should be obtained in females and homosexual males at high risk of being infected. Pharyngeal samples should be taken in females at high risk of being infected, especially when pharyngeal signs or symptoms are present.
{"title":"PCR for detection of Chlamydia trachomatis in endocervical, urethral, rectal, and pharyngeal swab samples obtained from patients attending an STD clinic.","authors":"L Ostergaard, T Agner, E Krarup, U B Johansen, K Weismann, E Gutschik","doi":"10.1136/sti.73.6.493","DOIUrl":"https://doi.org/10.1136/sti.73.6.493","url":null,"abstract":"<p><strong>Objective: </strong>To investigate, by use of the Amplicor PCR in a routine setting, the recovery rate of Chlamydia trachomatis in ano-rectal and pharyngeal swab samples obtained from males and females attending an STD clinic in relation to sexual practices, symptoms, and signs.</p><p><strong>Design: </strong>Data regarding sexual practices, and symptoms and signs related to the rectum and pharynx, were obtained from 196 females and 208 males, including 31 homosexuals and eight bisexuals. Swab samples were obtained from the urethra, rectum, and pharynx from all the patients. An additional endocervical swab sample was obtained from the females.</p><p><strong>Methods: </strong>All samples were analysed by the Amplicor PCR (Roche).</p><p><strong>Setting: </strong>Rudolph Bergh's Hospital, a clinic for sexually transmitted diseases situated in the centre of Copenhagen, Denmark.</p><p><strong>Results: </strong>The overall prevalence of urogenital C trachomatis infection was 9.2% (37/404). The specificity of the Amplicor PCR was 100% for both ano-rectal and pharyngeal swab samples. In females three (13%) of the 23 infections were detected only by testing an ano-rectal or throat swab sample. In homosexual males two (67%) of three infections were detected only by the anorectal swab sample. Ano-rectal intercourse without use of condom was reported by 44% of females and by 52% of homosexual males. Fellatio without condom use was reported by 91% of females, and 80% of heterosexual males practised cunnilingus. Pharyngeal infection, however, occurred only in females, and the presence of pharyngeal symptoms or signs seemed predictive for pharyngeal C trachomatis infection, for which the time of incubation or colonisation exceeded 3 months. The presence of ano-rectal signs or symptoms was not predictive for an ano-rectal C trachomatis infection.</p><p><strong>Conclusion: </strong>The Amplicor PCR can be used on ano-rectal and pharyngeal swab samples. Ano-rectal swab samples should be obtained in females and homosexual males at high risk of being infected. Pharyngeal samples should be taken in females at high risk of being infected, especially when pharyngeal signs or symptoms are present.</p>","PeriodicalId":12621,"journal":{"name":"Genitourinary Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/sti.73.6.493","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20503687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To define risk factors for gonococcal infection.
Methods: A case-control study comparing 200 gonorrhoea cases with 400 patients with non-gonococcal genitourinary infections and 400 patients with various skin diseases, all of them attending City Department for Skin and Venereal Diseases In Belgrade (Yugoslavia) from October 1993 to December 1994.
Results: According to multivariate logistic regression analysis the following factors were significantly related to gonorrhoea in men: education level, sexual contact same day as meeting, condom use, history of prior gonorrhoea, and casual and/or new sex partner in the past month. Age, sexual contact same day as meeting, number of partners in the past year, and frequency of sexual intercourse in the past month were independently, significantly related to gonorrhoea in women. Also, in females, gonorrhoea was significantly more frequent in industrial workers and supported people.
Conclusion: Since sexual behaviour, low education level, younger ages, and low socioeconomic status were found to be related to gonococcal infection, health education at early age seems to be the most appropriate means of altering high risk behaviour.
{"title":"Risk factors for gonorrhoea: case-control study.","authors":"M Bjekić, H Vlajinac, S Sipetić, J Marinković","doi":"10.1136/sti.73.6.518","DOIUrl":"https://doi.org/10.1136/sti.73.6.518","url":null,"abstract":"<p><strong>Objective: </strong>To define risk factors for gonococcal infection.</p><p><strong>Methods: </strong>A case-control study comparing 200 gonorrhoea cases with 400 patients with non-gonococcal genitourinary infections and 400 patients with various skin diseases, all of them attending City Department for Skin and Venereal Diseases In Belgrade (Yugoslavia) from October 1993 to December 1994.</p><p><strong>Results: </strong>According to multivariate logistic regression analysis the following factors were significantly related to gonorrhoea in men: education level, sexual contact same day as meeting, condom use, history of prior gonorrhoea, and casual and/or new sex partner in the past month. Age, sexual contact same day as meeting, number of partners in the past year, and frequency of sexual intercourse in the past month were independently, significantly related to gonorrhoea in women. Also, in females, gonorrhoea was significantly more frequent in industrial workers and supported people.</p><p><strong>Conclusion: </strong>Since sexual behaviour, low education level, younger ages, and low socioeconomic status were found to be related to gonococcal infection, health education at early age seems to be the most appropriate means of altering high risk behaviour.</p>","PeriodicalId":12621,"journal":{"name":"Genitourinary Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/sti.73.6.518","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20503692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: To determine the current utilisation of genitourinary medicine (GUM) services by general practitioners (GPs) and any changes likely to occur with moves towards a primary care led NHS.
Methods: A questionnaire survey of practising GPs appearing in the Medical Directory in England and Wales to determine the effect of geographical location, fundholding status, and potential effect of total fundholding on referrals to GUM clinics.
Results: Referral patterns for STDs varied according to the genital infection concerned, being highest for gonorrhoea and lowest for Trichomonas vaginalis infection. Referral patterns were little affected by geographic location of the practice or fundholding status. The reported intention on becoming total fundholding was a modest shift towards more STDs being treated in the community which varied according to the genital infection concerned.
Conclusions: Although some GPs elect to always treat some STDs in the community most refer patients to GUM clinics. There appears to be little enthusiasm among GPs, should they become total fundholders, to extend their range of services to include STD provision.
{"title":"Utilisation of genitourinary medicine services by general practitioners: effect of geographic location, fundholding status, and potential effect of total fundholding.","authors":"P D Woolley, S Chandiok","doi":"10.1136/sti.73.6.538","DOIUrl":"https://doi.org/10.1136/sti.73.6.538","url":null,"abstract":"<p><strong>Objectives: </strong>To determine the current utilisation of genitourinary medicine (GUM) services by general practitioners (GPs) and any changes likely to occur with moves towards a primary care led NHS.</p><p><strong>Methods: </strong>A questionnaire survey of practising GPs appearing in the Medical Directory in England and Wales to determine the effect of geographical location, fundholding status, and potential effect of total fundholding on referrals to GUM clinics.</p><p><strong>Results: </strong>Referral patterns for STDs varied according to the genital infection concerned, being highest for gonorrhoea and lowest for Trichomonas vaginalis infection. Referral patterns were little affected by geographic location of the practice or fundholding status. The reported intention on becoming total fundholding was a modest shift towards more STDs being treated in the community which varied according to the genital infection concerned.</p><p><strong>Conclusions: </strong>Although some GPs elect to always treat some STDs in the community most refer patients to GUM clinics. There appears to be little enthusiasm among GPs, should they become total fundholders, to extend their range of services to include STD provision.</p>","PeriodicalId":12621,"journal":{"name":"Genitourinary Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/sti.73.6.538","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20504345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Over the past few months guidelines for the treatment of HIV infection in adults have been published by groups in the United Kingdom (British HIV Association)' and the United States (US Department of Health and Human Services2 and the IAS-USA panel3). These have been prepared in response to rapidly emerging evidence from clinical trials of the clinical benefits of combination regimens for the treatment of HIV infection. On initial review the British group appears to have taken a more conservative therapeutic approach than its United States counterparts. However, in defining the principles of therapy there are major similarities particularly in the use of plasma HIV RNA levels (viral load) for initiating and monitoring therapy. Furthermore, guidelines are only as good as the current data on which they are based. Since the BHIVA guidelines were completed at the end of 1996 two large clinical endpoint studies have reported improved benefit of triple combination regimens compared with double nucleoside analogue combinations. Based on data from natural history studies and clinical endpoint treatment trials all three groups emphasise the importance of measuring plasma HIV RNA and CD4 counts for determining both the risk of disease progression and response to therapy. In addition, the reduction of plasma HIV RNA to below the levels of detection of a sensitive assay is viewed as the optimal treatment response by all groups. This stems from the observation that suppression of HIV replication limits potential for selection of HIV variants that are resistant to antiretroviral drugs. Failure to suppress HIV replication adequately is likely to lead to virological and clinical failure of the treatment regimen. Each of the guidelines discusses treatment regimens that are best able to achieve this treatment goal and in the light of current data few would argue with this principle of therapy although many acknowledge that this may not be achievable in all patients. There are, however, differences in the recommendations for initiating treatment (table) and choice of drug regimens. No clinical trial has determined the optimal time to start treatment and similar magnitudes of clinical benefit have been demonstrated at different stages of disease. In the absence of definitive data clinicians need to draw upon other levels of evidence to determine when to start treatment. Differences lie within the intepretation of this evidence and the expectation of long term benefit from current treatment regimens with the United States groups favouring earlier intervention and a heavier emphasis on the importance of plasma HIV RNA levels. If the main goal of therapy is to limit the risk of clinical progression to symptomatic disease then it seems reasonable for treatment to be offered before substantial immunodeficiency ensues and before the level of risk becomes too high. Recommendations of when to start treatment have therefore been based on studies of the natural history of HIV
{"title":"HIV therapy guidelines.","authors":"I G Williams","doi":"10.1136/sti.73.6.429","DOIUrl":"https://doi.org/10.1136/sti.73.6.429","url":null,"abstract":"Over the past few months guidelines for the treatment of HIV infection in adults have been published by groups in the United Kingdom (British HIV Association)' and the United States (US Department of Health and Human Services2 and the IAS-USA panel3). These have been prepared in response to rapidly emerging evidence from clinical trials of the clinical benefits of combination regimens for the treatment of HIV infection. On initial review the British group appears to have taken a more conservative therapeutic approach than its United States counterparts. However, in defining the principles of therapy there are major similarities particularly in the use of plasma HIV RNA levels (viral load) for initiating and monitoring therapy. Furthermore, guidelines are only as good as the current data on which they are based. Since the BHIVA guidelines were completed at the end of 1996 two large clinical endpoint studies have reported improved benefit of triple combination regimens compared with double nucleoside analogue combinations. Based on data from natural history studies and clinical endpoint treatment trials all three groups emphasise the importance of measuring plasma HIV RNA and CD4 counts for determining both the risk of disease progression and response to therapy. In addition, the reduction of plasma HIV RNA to below the levels of detection of a sensitive assay is viewed as the optimal treatment response by all groups. This stems from the observation that suppression of HIV replication limits potential for selection of HIV variants that are resistant to antiretroviral drugs. Failure to suppress HIV replication adequately is likely to lead to virological and clinical failure of the treatment regimen. Each of the guidelines discusses treatment regimens that are best able to achieve this treatment goal and in the light of current data few would argue with this principle of therapy although many acknowledge that this may not be achievable in all patients. There are, however, differences in the recommendations for initiating treatment (table) and choice of drug regimens. No clinical trial has determined the optimal time to start treatment and similar magnitudes of clinical benefit have been demonstrated at different stages of disease. In the absence of definitive data clinicians need to draw upon other levels of evidence to determine when to start treatment. Differences lie within the intepretation of this evidence and the expectation of long term benefit from current treatment regimens with the United States groups favouring earlier intervention and a heavier emphasis on the importance of plasma HIV RNA levels. If the main goal of therapy is to limit the risk of clinical progression to symptomatic disease then it seems reasonable for treatment to be offered before substantial immunodeficiency ensues and before the level of risk becomes too high. Recommendations of when to start treatment have therefore been based on studies of the natural history of HIV","PeriodicalId":12621,"journal":{"name":"Genitourinary Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/sti.73.6.429","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20503862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D Wilkinson, N Ndovela, A Harrison, M Lurie, C Connolly, A W Sturm
Objective: To determine the prevalence of asymptomatic and unrecognised genital tract infections among women attending a family planning clinic in rural South Africa.
Methods: 189 consecutive women had genital samples taken to diagnose infection with Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, Candida albicans, Treponema pallidum, and HIV, and to diagnose bacterial vaginosis.
Results: Mean age was 25 years; 155 (82%) were unmarried, 156 (83%) were currently using contraception, and 41 (22%) reported having an STD treated in the preceding 12 months. Although none volunteered abnormal urogenital symptoms, 74 (39%) had at least one elicited by direct questioning. 119 women (63%) had at least one genital infection: N gonorrhoeae (eight; 4%), C trachomatis (14; 8%), T vaginalis (26; 14%), C albicans (56; 30%), active syphilis (15; 8%), HIV (44; 24%), and bacterial vaginosis (29; 15%). 49 women (26%) had multiple infections. Most infections (71; 60%) were asymptomatic. Symptomatic women failed to recognise and report their symptoms, and routine services failed to detect the infections.
Conclusion: Prevalence of genital tract infection is high among these women, most infections are asymptomatic, and symptomatic infections are frequently not recognised. Women attending family planning clinics in such settings should be screened for syphilis and offered testing for HIV infection. Strategies to detect and treat other genital infections need to be developed.
{"title":"Family planning services in developing countries: an opportunity to treat asymptomatic and unrecognised genital tract infections?","authors":"D Wilkinson, N Ndovela, A Harrison, M Lurie, C Connolly, A W Sturm","doi":"10.1136/sti.73.6.558","DOIUrl":"https://doi.org/10.1136/sti.73.6.558","url":null,"abstract":"<p><strong>Objective: </strong>To determine the prevalence of asymptomatic and unrecognised genital tract infections among women attending a family planning clinic in rural South Africa.</p><p><strong>Methods: </strong>189 consecutive women had genital samples taken to diagnose infection with Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, Candida albicans, Treponema pallidum, and HIV, and to diagnose bacterial vaginosis.</p><p><strong>Results: </strong>Mean age was 25 years; 155 (82%) were unmarried, 156 (83%) were currently using contraception, and 41 (22%) reported having an STD treated in the preceding 12 months. Although none volunteered abnormal urogenital symptoms, 74 (39%) had at least one elicited by direct questioning. 119 women (63%) had at least one genital infection: N gonorrhoeae (eight; 4%), C trachomatis (14; 8%), T vaginalis (26; 14%), C albicans (56; 30%), active syphilis (15; 8%), HIV (44; 24%), and bacterial vaginosis (29; 15%). 49 women (26%) had multiple infections. Most infections (71; 60%) were asymptomatic. Symptomatic women failed to recognise and report their symptoms, and routine services failed to detect the infections.</p><p><strong>Conclusion: </strong>Prevalence of genital tract infection is high among these women, most infections are asymptomatic, and symptomatic infections are frequently not recognised. Women attending family planning clinics in such settings should be screened for syphilis and offered testing for HIV infection. Strategies to detect and treat other genital infections need to be developed.</p>","PeriodicalId":12621,"journal":{"name":"Genitourinary Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/sti.73.6.558","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20504957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}